Balanced news tone
News Sentiment
APM sentiment intelligence
Aptorum Group Ltd Class A news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-2.5% over one week, -8.8% over four weeks, trend inactive, and below fair value.
Aptorum Group Limited (APM) Edges Lower Amid Narrow Trading Range - Rating Change
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Up to $6M: Aptorum Group to Sell 1,000,000 Shares in Registered Direct Offering
Aptorum Group (NASDAQ: APM) announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2.0 million. Concurrently, the company will issue unregistered warrants to purchase up to 2,000,000 additional shares at the same price, po
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Oct 2025 05:02
- Source
- Stock Titan
Aptorum Group stock falls after $2 million direct offering By Investing.com
Aptorum Group Limited's stock tumbled 23% following the announcement of a $2 million registered direct offering and concurrent private placement. The biopharmaceutical company will sell 1,000,000 Class A ordinary shares at $2.00 per share and issue warrants to purchase up to 2,00
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Oct 2025 05:02
- Source
- Investing.com Australia
YOOV Group Holding Limited cancelled the acquisition of Aptorum Group Limited from Jurchen Investment Corporation and others in a reverse merger transaction.
YOOV Group Holding Limited has cancelled its acquisition of Aptorum Group Limited in a reverse merger transaction that was initially announced on March 1, 2024. The deal, valued at $250 million, would have resulted in YOOV shareholders owning approximately 90% of the combined com
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Oct 2025 05:02
- Source
- MarketScreener
Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
Aptorum Group Limited announced the completion of a private offering of a $3 million convertible note due in December 2023. The note was solely subscribed by Aenco Technologies Limited, an entity indirectly owned by Aptorum's Non-Executive Director and major shareholder, Mr. Ian
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Oct 2025 05:02
- Source
- Business Wire
Aptorum Group To Acquire U Group
Aptorum Group Limited announced its intention to acquire URF Holding Group Limited, a company focused on urban revitalization in China, through a non-binding Letter of Intent and Term Sheet. The acquisition, which involves a reverse takeover, will result in Aptorum distributing i
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 Oct 2025 05:02
- Source
- citybiz
Aptorum Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement | APM Stock News
Aptorum Group (APM) has regained compliance with Nasdaq's minimum bid price requirement by maintaining a closing bid price of at least $1.00 for ten consecutive business days between July 16 and July 30, 2025. This resolution addresses an earlier notice from Nasdaq dated April 15
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Oct 2025 05:02
- Source
- Quiver Quantitative
Aptorum Group raises $2 million in registered direct offering
Aptorum Group Limited has successfully raised $2 million through a registered direct offering of 1 million Class A ordinary shares priced at $2.00 per share, with a concurrent private placement potentially generating an additional $4 million from warrants. The biopharmaceutical c
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Oct 2025 19:32
- Source
- Investing.com India
Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
Aptorum Group Limited has announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2 million upfront. The offering also includes unregistered warrants to purchase up to an additional 2,000,000 shares, potentially generating
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 10 Oct 2025 09:54
- Source
- FinancialContent
APM | Aptorum Group Limited Class Institutional Ownership
This article provides an overview of Aptorum Group Limited (APM) Class A Ordinary Shares, focusing on institutional ownership, insider trading, and various financial metrics. It includes data sections for Congress trading, whale activity, corporate lobbying, revenue breakdown, an
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Sep 2025 12:51
- Source
- Quiver Quantitative
Aptorum Group’s Latest Surge: An Opportunity?
Aptorum Group Limited (APM) saw a significant stock surge of 134.65% following positive trial results, FDA designation announcements, and an impending all-stock merger with DiamiR Biosciences. The company also maintained NASDAQ compliance, positioning itself for potential growth
- Tone
- Positive 72/100
- Event
- Deals and strategy
- Published
- 21 Aug 2025 10:04
- Source
- StocksToTrade
Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement
Aptorum Group Limited has regained compliance with Nasdaq's minimum bid price requirement, fulfilling the condition of its Class A ordinary shares closing at $1.00 or higher for 10 consecutive business days. This comes after an initial notice from Nasdaq in April 2025. The compan
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 04 Aug 2025 08:15
- Source
- FinancialContent
APM Stock Price, News & Analysis
Aptorum Group Limited (NASDAQ: APM) is a clinical-stage biopharmaceutical company focused on oncology and infectious diseases, also involved in diagnostics and healthcare services. APM is currently undergoing an all-stock merger with DiamiR Biosciences Corp., which will make Diam
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 Apr 2025 19:39
- Source
- Stock Titan
Aptorum Group (APM) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 17:29
- Source
- Stock Titan
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Aptorum Group Limited announced it received a Nasdaq notification for not meeting the minimum bid price requirement of $1 per share. The company has a 180-calendar-day grace period until October 14, 2025, to regain compliance and is exploring options including a reverse stock spl
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 16 Apr 2025 12:27
- Source
- DC News Now
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
Aptorum Group Limited (NASDAQ: APM) announced it has entered into a securities purchase agreement with several institutional investors for a registered direct offering of 1,535,000 Class A Ordinary Shares at $2.00 per share, aiming to raise approximately $3.0 million. The offerin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2025 10:55
- Source
- FinancialContent